awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41658065-2F21EC67-29F6-4523-90EA-12C2EE3CDF60
Q41658065-2F21EC67-29F6-4523-90EA-12C2EE3CDF60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41658065-2F21EC67-29F6-4523-90EA-12C2EE3CDF60
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.
P2860
Q41658065-2F21EC67-29F6-4523-90EA-12C2EE3CDF60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41658065-2F21EC67-29F6-4523-90EA-12C2EE3CDF60
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2ecd8a011664be99cf974d8af0a3a17095e7222f
P2860
Phase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors.